To quantify the number and size of the tumors in each mouse, and to better understand the dynamics of lung tumor growth driven by these different oncogenic KRAS variants, we performed Tuba-seq on DNA extracted from bulk tumor-bearing lungs from mice across the different titers and timepoints (Supplementary Fig. 2A). The gene discussed is KRAS; the disease is neoplasm.